Join the Teplizumab group to help and get support from people like you.
Teplizumab News
Teplizumab Beneficial for Preserving Beta-Cell Function in Pediatric T1D
MONDAY, Oct. 23, 2023 – For children and adolescents with newly diagnosed type 1 diabetes, two 12-day courses of teplizumab show benefit for preservation of beta (β)-cell function, according to a ...
FDA Approves Tzield (teplizumab-mzwv) to Delay the Onset of Stage 3 Type 1 Diabetes
Tzield is the first disease-modifying therapy in T1D, a life-threatening autoimmune disease In a clinical trial, in Stage 2 T1D patients, Tzield delayed the median onset of Stage 3 T1D by 25 months,...
Ask a question
To post your own question to this support group, sign in or create an account.